Marketresearchnews

Sunday, 25 October 2020

Digital 3D Printing Market 2020 - Shares, Revenue, Analysis And Forecasts Till 2023

Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Digital 3D Printing Market Research Report - Forecast to 2023” Gives industry size, top players and worldwide demand

Digital 3D Printing Market Overview

Global digital 3D printing market is witnessing a constant rise in its revenues, mainly due to the rising adoption of 3D printing technology across industries. Some of the digital 3d printing market trends include the rapidly evolving 3D printing technology and increasing applications of this technology in the healthcare industry. 3D printing technologies have not only improved practices in the medical field but have also empowered manufacturers of medical devices and researchers, proving their worth in dental & orthodontic treatments, orthopedic implants, tissue engineering, and drug development.

The technology perceives a vast market demand that leads to increasing the size of the market on the global front. According to Market Research Future (MRFR), the global digital 3D printing market is poised to touch a valuation of USD 5,214.8 MN by 2025, registering 20.54% CAGR a throughout the forecast period (2019 – 2025). Rising advances in the digital 3D printing technology led by the rising R&D funding & initiatives of public-private sectors are the major growth drivers contributing to the growth of the market.

Also Read : https://www.medgadget.com/2020/03/global-digital-3d-printing-market-to-garner-huge-demand-from-the-healthcare-industry-asserts-mrfr-unleashing-the-forecast-for-2019-2025.html

Advantages that technology offers are boosting its application rate in the 3D printing market. Besides, the rising popularity of 3D printing technology among end-users is expected to push the market growth in the upcoming years. On the other hand, factors such as the lack of expertise and knowledge about the technology are acting as major growth impeders for the growth of the digital 3D printing industry.

Also, the slow adoption of the digital 3D printing technology is inhibiting the market growth extensively, especially in the developing regions such as the APAC and MEA. However, the situation is expected to improve dramatically over the assessment period.

Digital 3D Printing Market – Segments

The analysis is segmented into six main dynamics to widen the scope of understanding,

By Component: System/Device and Software/Services

By Material: Polymers, Metal & Alloy, Ceramics, and others.

By Technology: Stereo Lithography, Deposition Modeling, Laser Sintering Jetting Technology, Electron Beam Melting, and others.

By Applications: Dental (Clear Aligners, Dental Implants, Endosteal Implants, Sub-Periosteal Implants, Dentures Crowns & Bridges, others) Prosthetics (Prosthetics implants, Hip Disarticulation, Lower Limb/Extremity Componentry, Finger Splints, others), Orthopedics, Medical Components, Tissue Engineering (Bone & Cartilage Scaffolds, Ligament & Tendon Scaffolds, others), Hearing Aids, Drug Screening, and others.

By End User: Hospitals & Surgical Centers, Dental Clinics & Laboratories (Offices), Pharmaceutical & Biotechnology Companies, and others.

By Regions: Americas, Europe, Asia-Pacific, Middle East & Africa, and Rest-of-the-World

Global Digital 3D Printing Market – Regional Analysis

North America dominates the global digital 3D printing market. The largest market share attributes to the presence of established market players in the region and the augmenting demand for the digital 3D printing technology. Besides, medical device companies in the region, alongside the rising prevalence of diseases and increased adoption of medical devices in the treatment foster the growth of the market.

Moreover, digital 3D printing market trends, such as increasing advances and adoption of the technology is expected to drive the market growth further. Furthermore, the well-established 3D printing manufacturing industries in the region are substantiating the growth in the market excellently. In 2018, the US market held the largest share in the North American digital 3D printing market.

Europe stands second in the global digital 3D printing market, heading with the favorable government initiatives for the development of the technology. Rising prevalence of lifestyle diseases and the presence of well-established medical device industries in Germany, the UK, and France influence the regional market growth. The size of the digital 3D printing market in European territory is estimated to increase rapidly during the assessment period.

The digital 3D printing market in the Asia Pacific region is growing briskly attributing to the increasing per capita health spending, geriatric populaces, and incidence of accidents. Besides, the proliferating healthcare sectors in China, Japan, India, and Australia are substantiating the growth of the market.

Furthermore, the rising adoption of medical devices is a dominant driving force pushing the regional market growth forward. Substantial investments to expand 3D printing capabilities in rapidly developing APAC economies such as China, South Korea, Japan, and India are allowing the APAC digital 3D printing market to remain among the top leaders.

Digital 3D Printing Market – Competitive Analysis

Highly competitive, the digital 3D printing market appears well-established with the presence of several notable players. Players operating in the market strive to develop new products and thus their portfolio with cost-competitive prices. They make substantial R&D investments for the development of new products & technologies and to strengthen their market presence by expanding the distribution network and regional footprints. This further allows them to form collaborations and strategic initiations such as mergers & acquisitions, and others with other players in the digital 3D printing industry.

Digital 3D Printing Market Major Players:

Players leading the global digital 3D printing market include 3D Systems, Inc. (US), Stratasys Ltd (US), Carbon, Inc. (US), Formlabs (US), EnvisionTEC (US), ExOne (US), General Electric (US), Materialise (Europe), Micron Dental (US), and Renishaw PLC (UK), among others.

Digital 3D Printing Industry/ Innovation/ Related News

February 04, 2020 —– BellandTechnology AG (Germany), a leading chemical company, announced the completion of its acquisition of an Austria-based industrial 3D printer manufacturer – Xioneer Systems GmbH. Together with the consumables manufacturer, Xioneer Systems BellandTechnology is planning to expand its global presence on the markets for 3D printing and additive manufacturing.

The acquisition would enable the company to serve the FFF 3D printer market with software solutions, hardware components, and innovative concepts for 3D printing consumables. Also, as a 3D printing materials company, BellandTechnology would be working with all 3D printer manufacturers to deliver great products to manufacturers and end-users, which would further help the company to push its share in the FFF market forward.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/digital-3d-printing-market-8680

About Us:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Facial Fat Transfer Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Facial Fat Transfer Market Information, by Types (Microlipo-injection, Autologous Fat Transfer) by treatment types (fat injections, dermal fillers and others) – Forecast to 2022

KEY PLAYERS FOR FACIAL FAT TRANSFER MARKET

Galderma S.A., ALLERGAN, Merz Pharma, Valeant, Integra LifeSciences Corporation, Sanofi, Sinclair Pharma, SciVision Biotech Inc. and others.

Also Read : https://www.medgadget.com/2018/06/global-facial-fat-transfer-market-prognosticated-to-witness-a-ravishing-growth-usd-4-20-billion-by-2022-mrfr-unleashes-the-market-prognostications.html

MARKET SYNOPSIS FOR FACIAL FAT TRANSFER

Facial Fat Transfer/ Fat Grafting or Facial Fat Grafting refers to the corrective measures taken to treat serious facial deformities, natural (by birth) or occurred due to the accident, surgery or even due to the aging. Sounding so easy to perform, this treatment is far beyond than supplementing facial volume and filling in the creases like wrinkles and folds. Fat Transfer is not just a bioinert substance but a metabolically active and a live graft.

Hence, Facial Fat Transfer treatments are performed by the experts/ Cosmetic surgeons only. The procedure consists of harvesting small amounts of fat from other body parts like the thighs, abdomen, or hips and injecting into the areas of the face that have depleted volume. Thereby, erase wrinkles and reshape the face, enhancing the overall youthfulness of facial appearance.

Over the last decade, there has been a significant rise in the number of Facial Fat Transfer treatments performed worldwide. The probable factors persuading this rise are the influence of media, fashion and film industry peer pressure for appearance and beauty, and changing dynamics of beauty etc. Nonetheless, this rise has created a full-fledged, exclusive market space for Facial Fat Transfer. Once considered as merely a part of the cosmetic surgery, Facial Fat Transfer treatments is a mainstream market now. That too a flourishing market, needless to say.

Acknowledging the value this market is garnering currently and the growth prospect the market is demonstrating worldwide, Market Research Future (MRFR), recently published a brilliant study report giving out the complete market prognosis up till 2022. According to MRFR, the Global Facial Fat Transfer market is expected to accrue USD ~4.20 Billion by 2022, registering a phenomenal CAGR during the forecasted period (2016 -2022). In 2015, the market had valued USD 1.50 billion. The numbers indicate that the market is going to grow in three fold.

FACIAL FAT TRANSFER MARKET FOR COMPETITIVE LANDSCAPE

The global Facial Fat Transfer market is a fragmented market with a large number of players. Development strategies for the Treatment Types have been curtailed by the excellent efficiency and efficacy of the treatments. However, the rise of side effects/resistance have paved avenues for new treatment development and is an opportunity for a new market leader. The rise of spurious and counterfeit treatments have reduced the total market revenues and at the same time displaced standard treatments off the market. Key Players are focusing on innovative products & treatments with minimum adverse effects, as well as targeting emerging applications to leverage growth opportunities.

Industry/Innovations/Related News:

Bucks County Plastic Surgery & Dermatology, Pennsylvania announced that they have started offering fat transfer surgeries to Bucks County residents.

Facial Fat Transfer Global Market – Segments

For an easy grasp and enhanced understanding, MRFR has segmented the report into three key

By Types: Comprising – Autologous Fat Transfer and Microlipo Injection, among others.

By Treatment Types: Dermal fillers and Fat injections, among others.

By Regions: North America, Europe, APAC and Rest of the World.

FACIAL FAT TRANSFER MARKET FOR SEGMENT

Dermal fillers on the basis of Treatment Types accounts for the largest share of the global Facial Fat Transfer market.

FACIAL FAT TRANSFER MARKET FOR REGIONAL ANALYSIS

Geographically, North America accounts for the leading market for Facial Fat Transfer with the largest market share, followed by the markets of Europe & Asia Pacific, respectively. The market is growing due to the largest contribution from the significantly growing market of the US attributing to the high expenditure spent on the Facial Fat Transfer & health care. Continuing with the same growth trends, the North America market is likely to retain its dominance during the review period.

On the other hand, the growth of the world’s second-largest market for Facial Fat Transfer, Europe, is driven by the high per capita income and strong healthcare penetration in the region. The strong market growth in the countries like Germany & France drives the regional market growth in the large scale.

While Asia Pacific market for the Facial Fat Transfer is expected to perceive an exponential growth. The market growth will be led by China and India owing to the huge population and the burgeoning medical treatment market in the region. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/facial-fat-transfer-market-1780

About Us:

Contact Us:

Market Research Future, Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028 Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Thoracolumbar Spine Devices Market Statistical Analysis In 2020 By International Top 10 Players Till 2023

Thoracolumbar Spine Devices Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

MarketResearchFuture.com published a Half-Cooked research report on "Global Thoracolumbar Spine Devices Market Research Report - Forecast to 2023" reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Also Read : http://www.digitaljournal.com/pr/3713234

The global market for thoracolumbar spine devices is anticipated to grow at a CAGR of approximately 6.5% during the forecast period 2017-2023.

The report titled "Thoracolumbar Spine Devices Market -Forecast to 2023? is a direct appreciation by Market Research Future of the market potential of the Thoracolumbar Spine Devices Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today's winner takes all market!

Market Scenario:
The junction between the lumbar and thoracic part of the spine is known as thoracolumbar region. The thoracolumbar spine devices is used in this region to provide a steady support to the spine and avoid bending of thoracic spine. This minimal invasive devices is used as an alternative to spinal fusion surgery. The use of thoracolumbar spine devices ensures the retention of mobility of the spine, while spinal fusion surgery can cause movement ceastion.

The growing incidence of spinal disorders such as vertebral fracture, degenerative disc disease, spinal stenosis, and excessive kyphosis worldwide is driving the global thoracolumbar spine devices market. Further, fissures in the thoracolumbar region can be a major cause for surgical intrusion. These vertebral fractures are either caused through accidents or calcium and other mineral deficiency. This deficiency is caused due to osteoporosis and rickettsia that ultimately deteriorate the bone causing fractures.

Moreover, cases of spinal ailments such as spondylolisthesis and prolapsed intervertebral disc are rising globally. Besides, 80% of people suffer from lower back pain throughout the globe. All the above mentioned factors increase the adoption of thoracolumbar devices for treatment purposes.

Generally, open surgery can be a painful procedure and can require a prolonged hospital stay. This has resulted in rising inclination towards minimally invasive surgeries (MIS) amid patients, governments, healthcare providers, and others. The shift from traditional open surgeries to minimally invasive surgeries has improved the patient gratification owing to fast recovery and shorter hospital stay. The cumulative demand for minimally invasive spine surgery is one of the key factors that is clearly impacting the growth of the global thoracolumbar spine devices market.

Key Players:
Some of key the players in the global thoracolumbar spine devices market are Alphatec Holdings, Inc. (U.S.), B. Braun Melsungen AG (Germany), Depuy Synthes (Johnson & Johnson) (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), Medtronic Plc. (U.S.), NuVasive, Inc. (U.S.), Orthofix International N.V. (U.S.), Stryker Corporation (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Paragon Medical, Inc. (U.S.), Norman Noble, Inc. (U.S.), Nutech (India), Titan Spine (U.S.), Wenzel Spine, Inc. (U.S.), X-Spine Systems, Inc. (U.S.), Tecomet, Inc. (U.S.), Marox Corporation (U.S.), Axial Medical (U.S.), Spine Wave, Inc. (U.S.), K2M, Inc. (U.S.), Captiva Spine, LLC (U.S.), Coligne AG (Switzerland), Yellowsteps SAS (U.S.), Medyssey Co. Ltd. (South Korea), Aesculap Implant Systems, LLC (U.S.), Ulrich Medical (Germany), and others.

Segmentation:
The global thoracolumbar spine device market is segmented on the basis of product type, devices type, procedure, materials, and end user.

On the basis of product type, the global thoracolumbar spine device market can be segmented into instrumentation, implants, spine biologics, and other.

On the basis of devices type, the global thoracolumbar spine device market can be segmented into anterior stabilization device, posterior stabilization device, retractors, and other.

On the basis of procedure, the global thoracolumbar spine device market can be segmented into open surgery, minimally invasive surgery (MIS), and other.

On the basis of material, the global thoracolumbar spine device market can be segmented into titanium, stainless steel, and others.

On the basis of end user, the global thoracolumbar spine device market can be segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.

Intended Audience:
Thoracolumbar Spine Device Suppliers
Thoracolumbar Spine Device Manufacturers
Research and Development (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and Universities

Regional Analysis:
The global thoracolumbar spine devices market consists of regions namely America, Europe, Asia Pacific, and the Middle East & Africa.

The Americas region is estimated to dominate the market over the forecast period owing to the growing support by key players for outsourcing the manufacturing process to the developing economies. The large share of Americas region is due to expansion of the U.S. healthcare industry in the emerging economies.

The European market is anticipated to register a substantial growth owing to the increasing number of cases for spine disease, increasing geriatric population, technology advancements, and improving reimbursements. As per a study published in 2014 by the British Editorial Society of Bone and Joint Surgery, the rate for spinal fusion surgery for lumbar and cervical regions has augmented swiftly, however the rate of thoracic surgeries has declined over a period of time.

The Asia Pacific region is anticipated to emerge as the fastest growing thoracolumbar spine devices market owing to the increasing healthcare infrastructure, rising awareness among people, and large patient pool.

The Middle East & Africa has the potential to transpire as a large scale development and production hub for medical devices. The major factor contributing to this transformation would be low cost of product development in this region.\

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/thoracolumbar-spine-devices-market-5657

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

PEGylated drugs Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Recently MRFR, a leading market research firm collated a novel report on “Global PEGylated drugs Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

PEGylated Drugs Market Analysis

The global PEGylated drugs market is expected to exhibit a solid 5.53% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global PEGylated drugs market is expected to reach a valuation of USD 13.5 billion by 2025. The major drivers and restraints affecting the global PEGylated drugs market are profiled in the report to provide readers with a clear overview of the major factors determining the movement of the market. This provides readers with a clear overview of the movement of the market. The historical growth trajectory of the global PEGylated drugs market is also assessed in the report, along with forecasts for the market’s movement over the forecast period.

Also Read : http://www.digitaljournal.com/pr/3713234

PEGylation is the addition of a polyethylene glycol polymer to bioactive molecules such as proteins, peptides, enzymes, and others. The addition of PEG increases the efficacy of the bioactive molecules by making the molecule less detectable by the body’s immune system. It also increases the size of the molecule in a solution, increasing the amount of time before the renal system detects and excretes it. Hydrophobic drugs and molecules are also made water-soluble by PEGylation, which is a key factor driving the global PEGylated drugs market. Growing awareness about these benefits of PEGylation is likely to drive the global PEGylated drugs market.

Due to the growing awareness of the benefits of PEGylation, many leading companies are investing in PEGylation, leading to a more widespread interest in the process in the healthcare and life sciences sectors. Due to this significant investment, many companies have PEGylated molecules in the pipeline. Several PEGylated drugs have received FDA clearance and many are in the testing phase currently. On the other hand, adverse reactions to PEGylated drugs and consequent recalls are likely to be the major restraint on the global PEGylated drugs market over the forecast period.

PEGylated Drugs Market Competitive Leaderboard:

Leading players in the global PEGylated drugs market include Bayer AG, Takeda Pharmaceutical Company Ltd., Merck & Co. Inc., AstraZeneca, Amgen Inc., UCB SA, Novo Nordisk A/S, Pfizer Inc., F. Hoffman-La Roche Ltd., and Horizon Therapeutics plc. Leading players in the global PEGylated drugs market are focusing on product launches at the moment, as the regulatory environment is ripe for new product launches.

PEGylated Drugs Market Segmentation:

The global PEGylated drugs market is segmented on the basis of molecule, indication, and region.

By molecule, the global PEGylated drugs market is segmented into proteins, FAB fragments, enzyme, aptamers, and others. The proteins segment holds a dominant 64.8% share in the global PEGylated drugs market and is likely to remain in the driving seat over the forecast period due to the growing interest in PEGylated proteins.

By molecule, the global PEGylated drugs market is segmented into cancer, gout, hemophilia, hepatitis, and others.

PEGylated Drugs Market Regional Analysis:

The Americas hold a dominant share of 65.73% share in the global PEGylated drugs market. The strong position of the healthcare and life sciences sectors in North America is the major driver for the PEGylated drugs market in the Americas. Growing investment in PEGylated drugs is likely to result in steady growth of the market in the region over the forecast period. North America, led by the U.S., is the dominant regional market within the Americas and is likely to remain the dominant force over the forecast period. The rising prevalence of cancer in the region and the growing demand for effective drugs against the same is likely to be a major driver for the PEGylated drugs market in North America. The rising prevalence of hemophilia is also a major driver for the PEGylated drugs market.

Europe holds the second largest share in the global PEGylated drugs market. The rising occurrence of cancer in Europe is the major driver for the global PEGylated drugs market. Western Europe, comprising France, the UK, Germany, etc. is the dominant regional segment within Europe.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pegylated-drugs-market-8436

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Metabolomics Services Market Recent Trends, Growth Opportunities, Forecast By Application And Types To 2023

Metabolomics Services Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Metabolomics Services Market Analysis

The metabolomics services market size is predicted to touch USD 16,291.0 million at a 7.77% CAGR between 2016-2025, reveals the new Market Research Future (MRFR) report. Metabolomics is a study of unique chemical processes that are inside the cells and involves metabolites. This collection of metabolites in its entirety in an organism, organ, tissue, or biological cell is known as metabolome. These are the final products of cellular processes. Metabolomics is widely used in personalized medicine, functional genomics, nutrigenomics, toxicology testing, drug discovery, metabolomics profiling services such as biomarker discovery, among others.

Also Read : https://www.medgadget.com/2020/06/coronavirus-covid-19-impact-on-pegylated-drugs-market-2020-global-industry-analysis-merger-demand-overview-growth-rate-swot-analysis-top-leaders-forecast-to-2025.html

Numerous factors are adding to the metabolomics services market demand. Such factors, as revealed by the latest MRFR report, include increasing application in the biotechnological and life science industry, technological advances in instrumentation, and increasing incidence of diseases like cardiac diseases, neurological disorders, and cancer worldwide. Additional factors adding to the metabolomics services market share include the growing necessity for toxicology testing, burgeoning demand for personalized medicine, and rising biotech & pharmaceutical research and development expenditure.

On the contrary, strict government regulations/policies and high instrument cost are factors that may limit the metabolomics services market growth over the forecast period.

Metabolomics Services Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the metabolomics services market based on application and product & service.

By product & service, the metabolomics services market is segmented into mass spectrometry, metabolomics bioinformatics services, and chromatography. Chromatography is a method used in the laboratory to separate a mixture. It is of four types- paper chromatography, thin-layer chromatography, gas chromatography, and liquid chromatography. Bioinformatic tools and services are needed to perform essential functions like database functionalities and statistical analyses. It also helps researchers to decide that metabolites that are most meaningful biologically. Mass spectrometry is an advanced method to determine a compound’s molecular weight. Of these, metabolomics bioinformatics services will lead the market over the forecast period for its tremendous progress that is predicted to grow further for the use of parameter estimation techniques and robust algorithms in life-science analysis and research.

By application, the metabolomics services market is segmented into food, agriculture, biomedical, and pharmaceutical.

Metabolomics Services Market Regional Analysis

By region, the global metabolomics services market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period for the increasing incidence of cardiovascular diseases and cancer.

The global metabolomics services market in Europe is predicted to hold the second-largest share over the forecast period for the constant innovations in medical devices to augment the quality of life, increasing healthcare expenditure, and the presence of several top medical device companies in the region.

The global metabolomics services market in the APAC region is predicted to grow at a quick pace over the forecast period. Factors adding to the global metabolomics services market growth in the region include entry of leading companies, especially in developing countries, increase in R&D centers, growing disposable income, rising number of research and development organizations, and emerging healthcare infrastructure.

The global metabolomics services market in the MEA is predicted to have a small share during the forecast period for lack of adequate healthcare infrastructure and low per capita income.

Metabolomics Services Market Key Players

Leading players profiled in the global metabolomics services market report include Shimadzu Corporation (Japan), Human Metabolome Technologies America Inc. (Japan), Metabolon, INC (US), Creative Proteomics (US), Biocrates Life Sciences AG (Austria), Thermo Fisher Scientific (US), TMIC (Canada), Bruker (US), Agilent Technologies, Inc. (US), and Waters (US).

Metabolomics Services Industry News

March 2020: Regenr8 has joined hands with Physician’s Lab of Boca Raton to develop the first-ever epigenetic analysis- Epigenetic Biomarker Profile for determining the impact on an individual’s environment on his/her unique gene function by using the advanced diagnostic capabilities of the Physicians Lab for identifying different metabolites created from the enzymatic and metabolic cellular processes of tested individuals. This advanced metabolomic diagnostics will offer assessments of sleep markers, key vitamin markers, neurotransmitter metabolites, and much more.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pegylated-drugs-market-8436

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Pain Relief Medication Industry Overview By Growth Factors, Product Chain Value, Competitors Analysis And Forecast 2023

Pain Relief Medication Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Pain Relief Medication Market Overview:

Global report on the pain relief medication market reveals the potentials to achieve 4.73% CAGR within a period of 2019 to 2025, which has been defined as the forecast period by Market Research Future (MRFR).

The report contains factors like increasing expenditure capacity of the normal human beings, better inclusion in hospitals and various treatments, hike in research funding, better drug development technology using AI and other advanced technologies, hike in clearance rate, government support, and others that can ensure a rise in returns for the pain relief medication market.

Also Read : https://www.medgadget.com/2020/04/metabolomics-services-market-size-to-touch-usd-16291-0-million-at-7-77-cagr-by-2025.html

Pain Relief Medication Market Segmentation:

The global study of the pain relief medication market can be studied by having a strong foundation of details from segments like drug class, indication, and distribution channel. Their insights would help in developing tactical moves and enhance market profit.

By drug class, the study on the pain relief medication market can be segmented into opioids, COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, and others. The nonsteroidal anti-inflammatory drug segment would dominate as its inclusion is far better than others for its high efficacy rate. The opioids segment may turn out to be the fastest-growing as the awareness regarding its use is growing.

The global market study on pain relief medication can be segmented by indication into neuropathic pain, cancer pain, inflammatory conditions, musculoskeletal pain, and others. The cancer pain segment has the maximum market share. Recent market sales are showing a hike in the neuropathic pain segment due to a hike in rising economies.

By distribution channel, the pain relief medication market can be segmented into hospital & retail pharmacies and online pharmacies. The hospitals and retail pharmacies segment have the largest market share.

Pain Relief Medication Market Regional Analysis:

Global Pain Relief Medication Market, as discussed in the MRFR report, would see benefits from the Americas. This is primarily due to the rising concerns shown by companies in the region in terms of drug development. Hike in expenditure is boosting the process, and the market would favor all the moves by establishing procedures that would make the integration process of these drugs easier. Europe would develop similar strains using which the market would record high growth. France, Germany, the UK, Russia, Italy, and others are making substantial progress in the sector. They invest a notable amount of their budget in developing better infrastructure to assist various pharmaceutical companies in the manufacturing of these drugs.

The Asia Pacific region is getting acclaims as several regional companies from India, China, Japan, South Korea, and others are showing their keen interest in participating in the market. The massive population of the region would boost the regional market revenue. Also, various global brands are trying to explore the regional resource to expand their business, which might help the regional market outcome.

Pain Relief Medication Market Competitive Landscape:

The global pain relief medication market has a chance to benefit from strategic moves incorporated by several top-class companies like Allergan plc (Ireland), AbbVie Inc. (US), Bayer (Germany), Astellas Pharma Inc. (Japan), Boehringer Ingelheim International GmbH (Germany), Biogen Idec (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Bristol-Myers Squibb (US), Eli Lilly and Company (US), Pfizer, Inc. (the US), Sanofi (France), Purdue Pharma (US), and Teva Pharmaceutical Industries Ltd (Israel). The constant endeavor to set a firm foot in the market has led to the development of strategies that span across several pointers like mergers, collaborations, acquisitions, and others. Hike in research-related expenditure would also influence the market outcome.

Pain Relief Medication Industry News:

In March 2020, reports revealed that a shortage of raw materials of pain relief medication had been witnessed due to the global pandemic coronavirus. This has triggered a rise in the price of pain relief medication like Aspirin and all. In the UK, the price surged by 30% in some places. Individual drug makers are struggling to keep up with the pace of this change in the market.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435

About Market Research Future:

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Perfusion Imaging Market Worldwide Key Players Forecasts By Revenue, Growth Rate Till 2023

Global Perfusion Imaging Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Perfusion imaging market is a product and technology advancement driven market. The advancements in technology such as positron tomography which allows for qualitative real data about the organ under study. The latest development involve development of shorter life time radioactive materials thus reducing the radioactive exposure of the patient.

The rise of ageing population coupled with the rising cases of cardiac problems is the most important factor driving the market. Collaboration between large players and hospitals helps to reduce the costs and results in lower maintenance costs. It also results in greater market penetration and reduced marketing times and costs.

Also Read : https://www.medgadget.com/2019/04/perfusion-imaging-market-analysis-2019-growth-by-top-companies-and-trends-by-methods-and-by-application-forecast-analysis-to-2023.html

Perfusion imaging involves passage of fluid through the blood vessels of an organ and scanning, the flow of perfusion quality and quantity deviations from the normal using a number of medical imaging modalities. Radioactive material called tracers are mixed with blood and are injected into the organ to be studies using photographs by a special gamma camera which reveals qualitative and quantitative changes based on the supply of blood.

Single photon emission computed tomography is the latest technological advancement for perfusion imaging and is being seen as an alternative to positron emission tomography (PET).

Considering all these factors the market for perfusion imaging is expected to reach $ 12.03 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.2 % during 2017-2023.

Key players for Global Perfusion Imaging market:

Apollo Medical Imaging Technology Pty. Ltd.
Cigna, kmhlabs, Novadaq Technologies Inc.
GE Healthcare
Siemens Health
Philips Healthcare
Toshiba Medical Systems
NeuSoft
Bracco, and Lantheus Medical Cardiac Imaging Solutions Inc.
Perimed AB.
Positron
Aetna Inc. and others.

Segments:

The global perfusion imaging market is segmented on the basis of methods. Based on the methods, the market has been segmented as microspheres, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine and other. Based on the applications, the market has been segmented as ventilation perfusion imaging, myocardial perfusion imaging, functional brain imaging, testicular torsion detection and other.

Regional Analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/perfusion-radiology-market-8419

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com